Pavel Bobrov
Overview
Explore the profile of Pavel Bobrov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kupriyanova Y, Yurchenko I, Bobrov P, Bartels F, Wierichs S, Jonuscheit M, et al.
BMJ Open Diabetes Res Care
. 2025 Feb;
13(1).
PMID: 39965871
Introduction: The study aimed to assess the effect of COVID-19 on hepatic lipid (HL) content, fibrosis risk, and adiposity in persons with type 2 diabetes. Research Design And Methods: Participants...
2.
Sarabhai T, Kahl S, Gancheva S, Mastrototaro L, Dewidar B, Pesta D, et al.
Metabolism
. 2024 Dec;
164:156107.
PMID: 39721563
No abstract available.
3.
Jonuscheit M, Wierichs S, Rothe M, Korzekwa B, Mevenkamp J, Bobrov P, et al.
NMR Biomed
. 2024 Feb;
37(8):e5120.
PMID: 38404058
Concentrations of the key metabolites of hepatic energy metabolism, adenosine triphosphate (ATP) and inorganic phosphate (P), can be altered in metabolic disorders such as diabetes mellitus. Phosphorus (P)-magnetic resonance spectroscopy...
4.
Schon M, Prystupa K, Mori T, Zaharia O, Bodis K, Bombrich M, et al.
Lancet Diabetes Endocrinol
. 2023 Dec;
12(2):119-131.
PMID: 38142707
Background: Heterogeneity in type 2 diabetes can be represented by a tree-like graph structure by use of reversed graph-embedded dimensionality reduction. We aimed to examine whether this approach can be...
5.
Sarabhai T, Kahl S, Gancheva S, Mastrototaro L, Dewidar B, Pesta D, et al.
Metabolism
. 2023 Dec;
151:155762.
PMID: 38122893
Background: Obesity and type 2 diabetes frequently have metabolic dysfunction-associated steatotic liver disease (MASLD) including steatohepatitis (MASH). In obesity, the liver may adapt its oxidative capacity, but the role of...
6.
Zaharia O, Antoniou S, Bobrov P, Karusheva Y, Bodis K, Kupriyanova Y, et al.
Diabetes Care
. 2023 Oct;
46(12):2232-2239.
PMID: 37874983
Objective: Diabetes may feature impaired insulin kinetics, which could be aggravated by altered hepatic metabolism and glycemic control. Thus, we examined insulin clearance and its possible determinants in individuals with...
7.
Mitiureva D, Bobrov P, Rebreikina A, Sysoeva O
Int J Psychophysiol
. 2023 Jun;
190:42-55.
PMID: 37295728
Studying mu-rhythm in developmental disorders is crucial for identifying the origin of motor and social malfunctioning. However, the commonly used mu-rhythm experimental protocol, that requires following instructions, is challenging for...
8.
Liaukovich K, Sazhin S, Bobrov P, Ukraintseva Y
Int J Mol Sci
. 2022 Oct;
23(19).
PMID: 36233081
This work aimed to study the recovery of consciousness during forced awakening from slow-wave sleep (SWS) and rapid eye movement sleep (REM) in healthy volunteers. To track the changes in...
9.
Sarabhai T, Mastrototaro L, Kahl S, Bonhof G, Jonuscheit M, Bobrov P, et al.
Diabetologia
. 2022 Sep;
66(1):57-69.
PMID: 36178534
Aims/hypothesis: Hyperbaric oxygen (HBO) therapy may improve hyperglycaemia in humans with type 2 diabetes, but underlying mechanisms are unclear. Our objective was to examine the glucometabolic effects of HBO on...
10.
Bodis K, Knebel B, Nowotny B, Bobrov P, Kupriyanova Y, Zaharia O, et al.
Diabetes Res Clin Pract
. 2022 Feb;
185:109779.
PMID: 35176401
Carriers heterozygous for the D124N (c.370, GAC > AAC in exon 4) variant of GCK not only exhibit reduced insulin-secretion, but also impaired adipose insulin sensitivity, which may shift fatty...